Unveiling shared genetic pathways in cardiovascular diseases:towards personalized therapies and holistic treatment approaches  

作　　者：Jiang-Shan Tan Zhi-Qiang Liu Yi-Meng Wang Song Hu Yuan-Rui Deng Ling-Tao Chong Yan-Min Yang Lu Hua 

机构地区：[1]Emergency Center,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease of China,National Center for Cardiovascular Diseases,National Clinical Research Center of Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China [2]Fuwai Hospital,State Key Laboratory of Cardiovascular Disease of China,National Center for Cardiovascular Diseases,National Clinical Research Center of Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China

出　　处：《Aging Communications》2023年第4期7-8,共2页衰老通讯

摘　　要：Cardiovascular diseases(CVDs),encompassing diverse pathologies such as atherosclerosis,hypertension,cardiomyopathy,arrhythmia,and valvular diseases,represent a significant public health challenge,severely undermining human health[1].According to the World Health Organization,CVDs claimed approximately 17.9 million deaths in 2019,representing 32%of all global deaths[2,3].The risk of CVDs morbidity and mortality increases with age,with the majority of CVDs and deaths occurring in elderly aged 75 years and older[4,5].In developed nations,CVDs are the principal cause of mortality,while in developing countries,they are a leading cause of death as well.

关 键 词：diseases MORTALITY TREATMENT 

分 类 号：R54[医药卫生—心血管疾病]